Arterra Bioscience
ARBS.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 25.1% | -7.1% | -24.3% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 87.5% | 55.5% | 13.7% | 14.2% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | -€0 | -€0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | €0 | -€0 | €0 | €0 |
| % Margin | 35.2% | -10.7% | 10.2% | 40.5% |
| Other Income/Exp. Net | €0 | €0 | €0 | -€0 |
| Pre-Tax Income | €0 | €0 | €0 | €0 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 32% | 32.3% | 39.4% | 23.4% |
| EPS | 0.2 | 0.16 | 0.21 | 0.17 |
| % Growth | 25% | -23.8% | 23.5% | – |
| EPS Diluted | 0.2 | 0.16 | 0.21 | 0.17 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 48.9% | 55.3% | 65.1% | 37.3% |